|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 790.05 INR | -1.63% |
|
-3.82% | -3.91% |
| 07/01 | Senores Pharmaceuticals board approves issuance of warrants up to 950 million rupees | RE |
| 15/12 | Senores Pharmaceuticals to acquire Apnar Pharma | RE |
| Capitalization | 3.64TCr 40Cr 35Cr 32Cr 30Cr 56Cr 60Cr 370.19Cr 145.97Cr 1.74TCr 150.38Cr 147.29Cr 6.34TCr | P/E ratio 2026 * |
34.7x | P/E ratio 2027 * | 26x |
|---|---|---|---|---|---|
| Enterprise value | 3.64TCr 40Cr 35Cr 32Cr 30Cr 56Cr 60Cr 370.19Cr 145.97Cr 1.74TCr 150.38Cr 147.29Cr 6.34TCr | EV / Sales 2026 * |
6.08x | EV / Sales 2027 * | 4.54x |
| Free-Float |
-
| Yield 2026 * |
0.58% | Yield 2027 * | 0.84% |
More valuation ratios
* Estimated data
More news
| 1 day | -1.63% | ||
| 1 week | -3.82% | ||
| Current month | -3.91% | ||
| 1 month | -3.09% | ||
| 3 months | +10.04% | ||
| 6 months | +25.82% | ||
| Current year | -3.91% |
| 1 week | 787 |  | 832.55 |
| 1 month | 779.05 | | 876.5 |
| Current year | 787 | | 876.5 |
| 1 year | 440.3 | | 876.5 |
| 3 years | 435.25 | | 876.5 |
| 5 years | 435.25 | | 876.5 |
| 10 years | 435.25 | | 876.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 40 | 15/10/2021 | |
| Director of Finance/CFO | 62 | 01/01/2020 | |
| Chief Operating Officer | 59 | 10/11/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 10/11/2023 | |
| Director/Board Member | 62 | 01/01/2020 | |
| Director/Board Member | 46 | 23/11/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.63% | -3.82% | +67.92% | - | 41Cr | |
| +0.53% | -4.31% | +39.06% | +187.15% | 92TCr | |
| -0.41% | +6.27% | +50.83% | +26.08% | 53TCr | |
| -0.31% | -4.36% | +25.09% | +39.55% | 38TCr | |
| +0.93% | +2.80% | +31.21% | +19.61% | 37TCr | |
| +0.19% | -0.87% | +31.97% | +20.56% | 29TCr | |
| +0.98% | +1.62% | +27.62% | +36.80% | 27TCr | |
| -1.93% | -1.95% | +8.73% | -3.05% | 28TCr | |
| +6.49% | +5.01% | -35.72% | -16.95% | 25TCr | |
| +0.12% | +0.09% | +22.86% | +21.59% | 18TCr | |
| Average | +0.50% | -0.09% | +26.96% | +36.82% | 34.75TCr | |
| Weighted average by Cap. | +0.56% | +0.14% | +28.33% | +64.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 598.7Cr 6.6Cr 5.69Cr 5.3Cr 4.93Cr 9.18Cr 9.88Cr 61Cr 24Cr 285.58Cr 25Cr 24Cr 1.04TCr | 801.9Cr 8.84Cr 7.62Cr 7.09Cr 6.6Cr 12Cr 13Cr 82Cr 32Cr 382.51Cr 33Cr 32Cr 1.4TCr |
| Net income | 105Cr 1.16Cr 99.77L 92.87L 86.46L 1.61Cr 1.73Cr 11Cr 4.21Cr 50Cr 4.34Cr 4.25Cr 182.88Cr | 140.2Cr 1.55Cr 1.33Cr 1.24Cr 1.15Cr 2.15Cr 2.31Cr 14Cr 5.62Cr 67Cr 5.79Cr 5.68Cr 244.19Cr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
194
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 790.05 ₹ | -1.63% | 1,87,061 |
| 14/26/14 | 803.15 ₹ | -1.21% | 1,18,718 |
| 13/26/13 | 812.95 ₹ | -0.09% | 1,09,350 |
| 12/26/12 | 813.70 ₹ | +0.28% | 2,68,885 |
| 09/26/09 | 811.40 ₹ | -1.22% | 2,33,013 |
End-of-day quote NSE India S.E., January 16, 2026
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
790.05INR
Average target price
985.50INR
Spread / Average Target
+24.74%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SENORES Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition